Lisa Gill
Stock Analyst at JP Morgan
(2.95)
# 1,458
Out of 4,915 analysts
138
Total ratings
42.22%
Success rate
0.24%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintains: Overweight | $472 → $384 | $277.89 | +38.18% | 5 | Jul 22, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $405 → $418 | $239.82 | +74.30% | 8 | Jun 20, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $29 → $32 | $18.90 | +69.31% | 5 | May 28, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $180 → $190 | $171.12 | +11.03% | 3 | May 6, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Overweight | $29 → $30 | $19.62 | +52.91% | 2 | Mar 19, 2025 | |
| OPCH Option Care Health | Maintains: Overweight | $40 → $41 | $28.59 | +43.41% | 4 | Mar 6, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $14 → $17 | $13.10 | +29.77% | 4 | Mar 6, 2025 | |
| HUM Humana | Maintains: Neutral | $257 → $256 | $245.28 | +4.37% | 6 | Feb 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $80 → $81 | $61.90 | +30.87% | 5 | Feb 18, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $142 → $145 | $157.14 | -7.73% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $289 → $301 | $288.74 | +4.25% | 2 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $10.43 | +72.58% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $3.36 | +48.81% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $21.10 | +32.70% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $15 | $11.64 | +28.92% | 14 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $7.02 | +28.30% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $22 → $18 | $6.45 | +179.07% | 4 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $656 → $661 | $696.66 | -5.12% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $438 | $258.75 | +69.28% | 13 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $10.24 | +75.80% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $154.08 | +156.36% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $261 → $243 | $261.47 | -7.06% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $163.50 | +13.76% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $159.27 | -12.10% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $356.64 | -6.91% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $7 → $10 | $4.58 | +118.58% | 1 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $1.71 | +426.32% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.85 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $3.80 | +110.53% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $67.75 | +22.51% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $25.71 | +281.25% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $21.38 | - | 4 | Dec 19, 2017 |
Elevance Health
Jul 22, 2025
Maintains: Overweight
Price Target: $472 → $384
Current: $277.89
Upside: +38.18%
UnitedHealth Group
Jun 20, 2025
Maintains: Overweight
Price Target: $405 → $418
Current: $239.82
Upside: +74.30%
Privia Health Group
May 28, 2025
Maintains: Overweight
Price Target: $29 → $32
Current: $18.90
Upside: +69.31%
Quest Diagnostics
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $171.12
Upside: +11.03%
Concentra Group Holdings Parent
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $19.62
Upside: +52.91%
Option Care Health
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $28.59
Upside: +43.41%
Alignment Healthcare
Mar 6, 2025
Maintains: Neutral
Price Target: $14 → $17
Current: $13.10
Upside: +29.77%
Humana
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $245.28
Upside: +4.37%
CVS Health
Feb 18, 2025
Maintains: Overweight
Price Target: $80 → $81
Current: $61.90
Upside: +30.87%
Cardinal Health
Feb 4, 2025
Maintains: Neutral
Price Target: $142 → $145
Current: $157.14
Upside: -7.73%
Jan 24, 2025
Maintains: Overweight
Price Target: $289 → $301
Current: $288.74
Upside: +4.25%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $10.43
Upside: +72.58%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $3.36
Upside: +48.81%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $21.10
Upside: +32.70%
Aug 30, 2024
Maintains: Overweight
Price Target: $20 → $15
Current: $11.64
Upside: +28.92%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $7.02
Upside: +28.30%
Aug 21, 2024
Maintains: Underweight
Price Target: $22 → $18
Current: $6.45
Upside: +179.07%
Aug 21, 2024
Maintains: Overweight
Price Target: $656 → $661
Current: $696.66
Upside: -5.12%
Aug 21, 2024
Maintains: Overweight
Price Target: $435 → $438
Current: $258.75
Upside: +69.28%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $10.24
Upside: +75.80%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $154.08
Upside: +156.36%
May 30, 2024
Maintains: Overweight
Price Target: $261 → $243
Current: $261.47
Upside: -7.06%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $163.50
Upside: +13.76%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $159.27
Upside: -12.10%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $356.64
Upside: -6.91%
Mar 1, 2024
Upgrades: Overweight
Price Target: $7 → $10
Current: $4.58
Upside: +118.58%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $1.71
Upside: +426.32%
Dec 13, 2023
Downgrades: Underweight
Price Target: n/a
Current: $3.85
Upside: -
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $3.80
Upside: +110.53%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $67.75
Upside: +22.51%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $25.71
Upside: +281.25%
Dec 19, 2017
Downgrades: Neutral
Price Target: n/a
Current: $21.38
Upside: -